Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.

Katsuta E, Yan L, Takeshita T, McDonald KA, Dasgupta S, Opyrchal M, Takabe K.

Int J Mol Sci. 2019 Dec 28;21(1). pii: E217. doi: 10.3390/ijms21010217.

2.

Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy.

Asaoka M, Narui K, Suganuma N, Chishima T, Yamada A, Sugae S, Kawai S, Uenaka N, Teraoka S, Miyahara K, Kawate T, Sato E, Nagao T, Matsubara Y, Gandhi S, Takabe K, Ishikawa T.

Eur J Surg Oncol. 2019 Dec;45(12):2289-2294. doi: 10.1016/j.ejso.2019.08.001. Epub 2019 Aug 2.

PMID:
31787153
3.

High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer.

Takeshita T, Asaoka M, Katsuta E, Photiadis SJ, Narayanan S, Yan L, Takabe K.

Am J Transl Res. 2019 Oct 15;11(10):6507-6521. eCollection 2019.

4.

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor.

Takeshita T, Yan L, Asaoka M, Rashid O, Takabe K.

Sci Rep. 2019 Nov 15;9(1):16942. doi: 10.1038/s41598-019-53482-x.

5.

APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival.

Asaoka M, Ishikawa T, Takabe K, Patnaik SK.

Int J Mol Sci. 2019 Nov 10;20(22). pii: E5621. doi: 10.3390/ijms20225621.

6.

Current status and limitations of immunotherapy for breast cancer.

Tokumaru Y, Joyce D, Takabe K.

Surgery. 2019 Oct 14. pii: S0039-6060(19)30674-9. doi: 10.1016/j.surg.2019.09.018. [Epub ahead of print] No abstract available.

PMID:
31623855
7.

Do Preys Prey on Their Predators? Confusion Over Predatory "Hage-taka" Journals.

Takabe K, Nagahashi M, Butash AL, Wakai T.

Japan Med Assoc J. 2019 Sep 4;2(2):200-201. doi: 10.31662/jmaj.2019-0011. Epub 2019 Jun 6.

8.

Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.

Narayanan S, Kawaguchi T, Peng X, Qi Q, Liu S, Yan L, Takabe K.

Sci Rep. 2019 Sep 17;9(1):13455. doi: 10.1038/s41598-019-49878-4.

9.
10.

Primary and secondary breast angiosarcoma: single center report and a meta-analysis.

Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M.

Breast Cancer Res Treat. 2019 Dec;178(3):523-533. doi: 10.1007/s10549-019-05432-4. Epub 2019 Sep 14. Review.

11.

Elastographic Tomosynthesis From X-Ray Strain Imaging of Breast Cancer.

Sutphin C, Olson E, Motai Y, Lee SJ, Kim JG, Takabe K.

IEEE J Transl Eng Health Med. 2019 Aug 19;7:4300312. doi: 10.1109/JTEHM.2019.2935721. eCollection 2019.

12.

Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.

Okano M, Oshi M, Butash AL, Katsuta E, Tachibana K, Saito K, Okayama H, Peng X, Yan L, Kono K, Ohtake T, Takabe K.

Int J Mol Sci. 2019 Aug 27;20(17). pii: E4197. doi: 10.3390/ijms20174197.

13.

Dual Scan Mammoscope (DSM) - A New Portable Photoacoustic Breast Imaging System with Scanning in Craniocaudal Plane.

Nyayapathi N, Takabe K, Xia J, Lim R, Zhang H, Zheng W, Wang Y, Tiao M, Oh KW, Fan XC, Bonaccio E.

IEEE Trans Biomed Eng. 2019 Aug 19. doi: 10.1109/TBME.2019.2936088. [Epub ahead of print]

PMID:
31425013
14.

Intra- and Interspecies Variability of Single-Cell Innate Fluorescence Signature of Microbial Cell.

Yawata Y, Kiyokawa T, Kawamura Y, Hirayama T, Takabe K, Nomura N.

Appl Environ Microbiol. 2019 Aug 29;85(18). pii: e00608-19. doi: 10.1128/AEM.00608-19. Print 2019 Sep 15.

15.

Sphingosine-1-Phosphate Facilitates Skin Wound Healing by Increasing Angiogenesis and Inflammatory Cell Recruitment with Less Scar Formation.

Aoki M, Aoki H, Mukhopadhyay P, Tsuge T, Yamamoto H, Matsumoto NM, Toyohara E, Okubo Y, Ogawa R, Takabe K.

Int J Mol Sci. 2019 Jul 10;20(14). pii: E3381. doi: 10.3390/ijms20143381.

16.

Proton Gradient-Dependent Transport of p-Glucocoumaryl Alcohol in Differentiating Xylem of Woody Plants.

Tsuyama T, Matsushita Y, Fukushima K, Takabe K, Yazaki K, Kamei I.

Sci Rep. 2019 Jun 20;9(1):8900. doi: 10.1038/s41598-019-45394-7.

17.

High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma.

Takahashi H, Katsuta E, Yan L, Dasgupta S, Takabe K.

Surgery. 2019 Aug;166(2):150-156. doi: 10.1016/j.surg.2019.04.011. Epub 2019 Jun 3.

PMID:
31171367
18.

Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.

Okano M, Oshi M, Butash AL, Asaoka M, Katsuta E, Peng X, Qi Q, Yan L, Takabe K.

Int J Mol Sci. 2019 May 30;20(11). pii: E2655. doi: 10.3390/ijms20112655.

19.

Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.

Maiti A, Qi Q, Peng X, Yan L, Takabe K, Hait NC.

Int J Oncol. 2019 Jul;55(1):116-130. doi: 10.3892/ijo.2019.4796. Epub 2019 May 6.

20.

Clinical application of ceramide in cancer treatment.

Moro K, Nagahashi M, Gabriel E, Takabe K, Wakai T.

Breast Cancer. 2019 Jul;26(4):407-415. doi: 10.1007/s12282-019-00953-8. Epub 2019 Apr 8. Review.

PMID:
30963461
21.

Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.

McDonald KA, Kawaguchi T, Qi Q, Peng X, Asaoka M, Young J, Opyrchal M, Yan L, Patnaik S, Otsuji E, Takabe K.

Ann Surg Oncol. 2019 Jul;26(7):2191-2199. doi: 10.1245/s10434-019-07338-3. Epub 2019 Apr 8.

PMID:
30963401
22.

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.

Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, Xiao Y, Yu KD, Liu YR, Yu Y, Zheng Y, Li X, Zhang C, Hu P, Zhang J, Hua Q, Zhang J, Hou W, Ren L, Bao D, Li B, Yang J, Yao L, Zuo WJ, Zhao S, Gong Y, Ren YX, Zhao YX, Yang YS, Niu Z, Cao ZG, Stover DG, Verschraegen C, Kaklamani V, Daemen A, Benson JR, Takabe K, Bai F, Li DQ, Wang P, Shi L, Huang W, Shao ZM.

Cancer Cell. 2019 Mar 18;35(3):428-440.e5. doi: 10.1016/j.ccell.2019.02.001. Epub 2019 Mar 7.

PMID:
30853353
23.

Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling.

Zhang J, Gelman IH, Katsuta E, Liang Y, Wang X, Li J, Qu J, Yan L, Takabe K, Hochwald SN.

Cell Mol Gastroenterol Hepatol. 2019;8(1):37-60. doi: 10.1016/j.jcmgh.2019.02.009. Epub 2019 Mar 2.

24.

BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer.

Shimada Y, Muneoka Y, Nagahashi M, Ichikawa H, Tajima Y, Hirose Y, Ando T, Nakano M, Sakata J, Kameyama H, Takii Y, Ling Y, Okuda S, Takabe K, Wakai T.

Sci Rep. 2019 Feb 21;9(1):2466. doi: 10.1038/s41598-019-39328-6.

25.

Pancreatic adenocarcinomas with mature blood vessels have better overall survival.

Katsuta E, Qi Q, Peng X, Hochwald SN, Yan L, Takabe K.

Sci Rep. 2019 Feb 4;9(1):1310. doi: 10.1038/s41598-018-37909-5.

26.

SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.

Oyanagi H, Shimada Y, Nagahashi M, Ichikawa H, Tajima Y, Abe K, Nakano M, Kameyama H, Takii Y, Kawasaki T, Homma KI, Ling Y, Okuda S, Takabe K, Wakai T.

Histopathology. 2019 May;74(6):873-882. doi: 10.1111/his.13805. Epub 2019 Apr 1.

27.

Clinical target sequencing for precision medicine of breast cancer.

Tsuchida J, Rothman J, McDonald KA, Nagahashi M, Takabe K, Wakai T.

Int J Clin Oncol. 2019 Feb;24(2):131-140. doi: 10.1007/s10147-018-1373-5. Epub 2019 Jan 2. Review.

PMID:
30604156
28.

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy.

Katsuta E, Oshi M, Rashid OM, Takabe K.

J Vis Exp. 2018 Nov 29;(141). doi: 10.3791/57849.

PMID:
30582603
29.

Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.

Hoki T, Katsuta E, Yan L, Takabe K, Ito F.

J Surg Res. 2019 Feb;234:343-352. doi: 10.1016/j.jss.2018.11.008.

PMID:
30527495
30.

Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients.

Sporn JC, Katsuta E, Yan L, Takabe K.

J Surg Res. 2019 Jan;233:426-435. doi: 10.1016/j.jss.2018.08.020. Epub 2018 Sep 20.

PMID:
30502282
31.

Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions.

Shimada Y, Tajima Y, Nagahashi M, Ichikawa H, Oyanagi H, Okuda S, Takabe K, Wakai T.

J Surg Res. 2018 Dec;232:72-81. doi: 10.1016/j.jss.2018.06.020. Epub 2018 Jul 3.

PMID:
30463788
32.

Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.

Yuza K, Nakajima M, Nagahashi M, Tsuchida J, Hirose Y, Miura K, Tajima Y, Abe M, Sakimura K, Takabe K, Wakai T.

J Surg Res. 2018 Dec;232:186-194. doi: 10.1016/j.jss.2018.06.019. Epub 2018 Jul 6.

PMID:
30463717
33.

The Roles of Sphingosine Kinases in Skin Aging.

Aoki M, Aoki H, Mukhopadhyay P, Katsuta E, Takabe K.

J Invest Dermatol. 2019 Apr;139(4):951-953. doi: 10.1016/j.jid.2018.06.192. Epub 2018 Oct 24. No abstract available.

PMID:
30367873
34.

ASO Author Reflections: "From Computer to Bedside": A New Translational Approach to Immunogenomics.

Kawaguchi T, Narayanan S, Takabe K.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):846-847. doi: 10.1245/s10434-018-6957-9. Epub 2018 Oct 26. No abstract available.

35.

Next generation sequencing-based gene panel tests for the management of solid tumors.

Nagahashi M, Shimada Y, Ichikawa H, Kameyama H, Takabe K, Okuda S, Wakai T.

Cancer Sci. 2019 Jan;110(1):6-15. doi: 10.1111/cas.13837. Epub 2018 Nov 27. Review.

36.

Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.

Kawaguchi T, Yan L, Qi Q, Peng X, Edge SB, Young J, Yao S, Liu S, Otsuji E, Takabe K.

Ann Surg Oncol. 2018 Dec;25(13):4037-4046. doi: 10.1245/s10434-018-6859-x. Epub 2018 Oct 11.

37.

Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer.

Yuza K, Nagahashi M, Shimada Y, Nakano M, Tajima Y, Kameyama H, Nakajima M, Takabe K, Wakai T.

J Surg Res. 2018 Nov;231:323-330. doi: 10.1016/j.jss.2018.05.085. Epub 2018 Jun 28.

PMID:
30278948
38.

The role of sphingosine-1-phosphate in inflammation and cancer progression.

Nagahashi M, Abe M, Sakimura K, Takabe K, Wakai T.

Cancer Sci. 2018 Dec;109(12):3671-3678. doi: 10.1111/cas.13802. Epub 2018 Oct 15. Review.

39.

Distribution of Lignin, Hemicellulose, and Arabinogalactan Protein in Hemp Phloem Fibers.

Kiyoto S, Yoshinaga A, Fernandez-Tendero E, Day A, Chabbert B, Takabe K.

Microsc Microanal. 2018 Aug;24(4):442-452. doi: 10.1017/S1431927618012448.

PMID:
30175708
40.

Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma.

Nagahashi M, Sato S, Yuza K, Shimada Y, Ichikawa H, Watanabe S, Takada K, Okamoto T, Okuda S, Lyle S, Takabe K, Tsuchida M, Wakai T.

J Surg Res. 2018 Oct;230:181-185. doi: 10.1016/j.jss.2018.07.007. Epub 2018 Jul 30.

PMID:
30072189
41.

Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis.

Hirose Y, Nagahashi M, Katsuta E, Yuza K, Miura K, Sakata J, Kobayashi T, Ichikawa H, Shimada Y, Kameyama H, McDonald KA, Takabe K, Wakai T.

Sci Rep. 2018 Jul 17;8(1):10814. doi: 10.1038/s41598-018-29144-9.

42.

Genomic characterization of colitis-associated colorectal cancer.

Kameyama H, Nagahashi M, Shimada Y, Tajima Y, Ichikawa H, Nakano M, Sakata J, Kobayashi T, Narayanan S, Takabe K, Wakai T.

World J Surg Oncol. 2018 Jul 2;16(1):121. doi: 10.1186/s12957-018-1428-0. Review.

43.

A new monoclonal antibody against rhamnogalacturonan II and its application to immunocytochemical detection of rhamnogalacturonan II in Arabidopsis roots.

Zhou Y, Kobayashi M, Awano T, Matoh T, Takabe K.

Biosci Biotechnol Biochem. 2018 Oct;82(10):1780-1789. doi: 10.1080/09168451.2018.1485479. Epub 2018 Jun 18.

PMID:
29912643
44.

The mechanism of two-phase motility in the spirochete Leptospira: Swimming and crawling.

Tahara H, Takabe K, Sasaki Y, Kasuga K, Kawamoto A, Koizumi N, Nakamura S.

Sci Adv. 2018 May 30;4(5):eaar7975. doi: 10.1126/sciadv.aar7975. eCollection 2018 May.

45.

Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.

Dhakal A, Matthews CM, Levine EG, Salerno KE, Zhang F, Takabe K, Early AP, Edge SB, O'Connor T, Khoury T, Young JS, Opyrchal M.

Clin Breast Cancer. 2018 Dec;18(6):e1401-e1405. doi: 10.1016/j.clbc.2018.04.015. Epub 2018 Apr 28.

46.

Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.

Narayanan S, Kawaguchi T, Yan L, Peng X, Qi Q, Takabe K.

Ann Surg Oncol. 2018 Aug;25(8):2323-2331. doi: 10.1245/s10434-018-6506-6. Epub 2018 May 16.

47.

A high burden of comorbid conditions leads to decreased survival in breast cancer.

Woelfel IA, Fernandez LJ, Idowu MO, Takabe K.

Gland Surg. 2018 Apr;7(2):216-227. doi: 10.21037/gs.2018.02.03.

48.

Intravital microscopy in the study of the tumor microenvironment: from bench to human application.

Gabriel EM, Fisher DT, Evans S, Takabe K, Skitzki JJ.

Oncotarget. 2018 Apr 13;9(28):20165-20178. doi: 10.18632/oncotarget.24957. eCollection 2018 Apr 13. Review.

49.

Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.

Moro K, Kawaguchi T, Tsuchida J, Gabriel E, Qi Q, Yan L, Wakai T, Takabe K, Nagahashi M.

Oncotarget. 2018 Apr 13;9(28):19874-19890. doi: 10.18632/oncotarget.24903. eCollection 2018 Apr 13.

50.

Pseudocirrhosis after chemotherapy in breast cancer, case reports.

Aoyagi T, Takabe K, Tamanuki T, Matsubara H, Matsuzaki H.

Breast Cancer. 2018 Sep;25(5):614-618. doi: 10.1007/s12282-018-0865-5. Epub 2018 Apr 25.

PMID:
29696562

Supplemental Content

Loading ...
Support Center